Pharmaceutical

Studies show top surgery is safe for fat patients, but ...

Even if they can make it past the normal hurdles, fat transmasculine people say ...

Sanofi’s frexalimab shows early potential in in Phase I...

The anti-CD 40L antibody was associated with a a significant reduction in lesion...

AstraZeneca and MSD’s Lynparza combo bags FDA approval ...

The approval is for the use of Lynparza in combination with Zytiga and prednison...

Pneumagen raises £8 million for further study of intran...

The Scottish company raised further funding to fuel an upcoming Phase IIb study ...

InDex Pharmaceuticals signs licence deal with Viatris f...

InDex will provide funding for the Phase III CONCLUDE programme, an Induction St...

Algernon announces acceptance of Repirinast patent appl...

Repirinast was previously marketed under the brand name Romet in Japan to treat ...

Negative FDA AdCom vote for Intercept’s obeticholic aci...

Additionally, panellists expressed doubts regarding Intercept’s use of a surroga...

UK’s NICE recommends Pfizer’s rimegepant to treat migraine

Up to 145,000 people in England will have the option to choose this treatment.

USPTO grants Notice of Allowance for Tenax Therapeutics...

The patent for oral levosimendan is based on findings obtained from the HELP Study.

New UK intracellular drug delivery centre to support RN...

The new centre will provide access to the infrastructure required to accelerate ...

FDA approves Analog and Dipharma’s ANDA for nitisinone ...

Nitisinone capsules are generic equivalent of Swedish Orphan Biovitrum's Orfadin.

FDA approves Pfizer’s RSV vaccine for older adults

The Food and Drug Administration approved a second vaccine to protect older adul...

STAT+: CVS warns PBM reforms ‘could lead to higher costs’

A top executive at CVS Health said the company would find ways to maintain its l...

House Republicans demand career scientist explain patho...

The Republicans' request stokes a long-running argument about whether pathogen-a...

STAT+: Pharmalittle: Appeals court rules Purdue can shi...

A U.S. appeals court ruled that Purdue Pharma can shield its owners from lawsuit...

Opinion: Newly diagnosed cancer patients need help navi...

So you have cancer. Now what?